Harbor Capital Advisors’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.27M Buy
271,856
+10,135
+4% +$44.5K 0.09% 305
2026
Q2
$1.01M Sell
261,721
-1,648
-0.6% -$6.02K 0.07% 357
2026
Q1
$1.04M Sell
263,369
-43,297
-14% -$218K 0.08% 318
2025
Q4
$2.08M Sell
306,666
-29,097
-9% -$204K 0.16% 165
2025
Q3
$2.34M Sell
335,763
-833,432
-71% -$5.79M 0.18% 146
2025
Q2
$7.14M Buy
1,169,195
+125,519
+12% +$835K 0.3% 105
2025
Q1
$7.93M Buy
1,043,676
+42,288
+4% +$353K 0.36% 86
2024
Q4
$9.6M Sell
1,001,388
-26,350
-3% -$205K 0.42% 67
2024
Q3
$6.07M Buy
1,027,738
+770,744
+300% +$5.11M 0.26% 114
2024
Q2
$1.78M Buy
+256,994
New +$1.81M 0.14% 230

Other funds holding MDXG

Harbor Capital Advisors's MDXG Position: Q3 2026 in Review

Harbor Capital Advisors increased its MiMedx Group (MDXG) stake by 3.9% in Q3 2026, buying an estimated $44.5K and bringing the position to 271,856 shares worth $1.27M. The position accounts for 0.09% of the portfolio, ranked #305.

Harbor Capital Advisors first reported a position in MDXG in Q2 2024 and has held it in 10 quarters since. The position peaked at $9.6M in Q4 2024. 217 funds tracked by Wall St. Rank hold MDXG as of Q3 2026.

  • Harbor Capital Advisors held 271,856 shares of MiMedx Group worth $1.27M as of Q3 2026.
  • Harbor Capital Advisors bought 10,135 MiMedx Group shares in Q3 2026, an estimated $44.5K.
  • MiMedx Group made up 0.09% of Harbor Capital Advisors's portfolio in Q3 2026, its #305 holding.
  • Harbor Capital Advisors first reported a position in MiMedx Group in Q2 2024 and has held it in 10 quarters since.
  • Harbor Capital Advisors's MiMedx Group position peaked at $9.6M in Q4 2024.
  • 217 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2026.

Based on Harbor Capital Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.